To apply data statistics to analyze the drug use rules of Professor Li Jun in the treatment of coronary heart disease.Based on the software of the TCM Inheritance Auxiliary Platform, the 2015-2017 coronary heart disease cases treated by Professor Li Jun, a famous old Chinese medicine doctor in Shaanxi Province, were collected, and 50 valid cases were screened out from them, and a party database of coronary heart disease was constructed, and the data collection and analysis functions of the software were used to analyze the input data for statistical analysis of drug frequency, prescription rules, and new prescriptions. Among the 50 prescriptions for the treatment of coronary heart disease, a total of 80 Chinese medicines were involved; the most frequent drug use was: Pinellia Ternate,Pericarpium Citri Reticulate , the root of Kudzu Vine,Ground Beetle, Ligusticum Wallichii; the five places with the highest frequency of drug combinations were: "Pinellia Ternate, Pericarpium Citri Reticulate", "Pinellia Ternate,the root of Kudzu Vine", "Pinellia Ternate, Ground Beetle", "Pericarpium Citri Reticulate, the root of Kudzu Vine", "Pinellia Ternate, Pericarpium Citri Reticulate, the root of kudzu Vine",and 18 drug core combinations and 9 new combinations were excavated. Taking sputum stasis as the basic mechanism for the treatment of coronary heart disease,the treatment method of gasification of phlegm and blood circulation is adopted, and the clinical effect is remarkable, which provides a broader reference value for the clinical treatment of coronary heart disease.

Yu Zhang, Jun Li, Youcai Yuan. Study on the Drug Use Pattern of Professor Li Jun's Treatment of Coronary Heart Disease Based on Association Rules and Entropy Clustering of Complex Systems. Frontiers in Medical Science Research (2023) Vol. 5, Issue 7: 119-124. https://doi.org/10.25236/FMSR.2023.050719.

[1] Yan Hongbing. Guidelines for the diagnosis and treatment of clinical coronary heart disease[M]. Beijing: People's Medical Publishing House, 2010:76-77.

[2] Chen Yushu, Wang Kerang. Liu Xuan. Four Medical Cases Selection of Jizhitang Medical Cases[J]. Journal of Xingyuan Traditional Chinese Medicine Literature, 1994, (1X):8-10.

[3] Tian Panpan, Wu Xiaobo, Zhao Wei, Li Jun. Professor Li Jun′s Experience in Treating Angina Pectoris of Coronary Heart Disease[J].World Journal of Integrated Traditional and Western Medicine, 2021, 16(2):270-273.

[4] Zhu Chunlin, Li Ruihan, Jing Ruiqing, Huang Li. Prescription Regularity of Traditional Chinese Medicine in the Treatment of Coronary Heart Disease in Ancient and Modern Literatures[J]. Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease, 2022, 04:586-591.

[5] He Xinxin, Wang Junyan, Song Yan, Jia Lianqun, Yang Guanlin, Chen Wenna, Zhang Zhe. Potential Molecular Mechanisms of Puerarin in Treatment of Atherosclerosis Based on Network Pharmacology[J].Chinese Archives of Traditional Chinese Medicine, 2020, 09:116-120+262-263.

[6] Shi Chenxu, Du Jiarong, Wu Wei, Liu Lianxuan, Yang Guanlin, Zhang Huiyong. Chemical Constituents and Pharmacological Action of Puerariae Lobatae Radix: A Review[J]. Modern Chinese Medicine, 2021, 12:2177-2195.

[7] Zhao Xinwang, Xu Wenhua, Zhao Yang, Wu Yanhong, Luo Wei, Zhu Ziming, Zheng Jinghui. Action mechanisms of Chuanxiong Rhizoma in treating coronary heart disease based on network pharmacology [J].Chinese Traditional Patent Medicine, 2019, 09:2096-2101.